About Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome
Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome is a rare disease catalogued by Orphanet (ORPHA:294023). It is associated with the ADAM17 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome trials.
Search ClinicalTrials.gov for "Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome" or filter by Orphanet code ORPHA:294023 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome. Updated daily.